Vonk Marlotte M, Diks Mara A P, Wagenaar Laura, Smit Joost J, Pieters Raymond H H, Garssen Johan, van Esch Betty C A M, Knippels Léon M J
Faculty of Science, Department of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.
Immunology Platform, Nutricia Research, Utrecht, Netherlands.
Front Immunol. 2017 Sep 29;8:1230. doi: 10.3389/fimmu.2017.01230. eCollection 2017.
Oral immunotherapy (OIT) is a promising therapeutic approach to treat food allergic patients. However, there are some concerns regarding its safety and long-term efficacy. The use of non-digestible oligosaccharides might improve OIT efficacy since they are known to directly modulate intestinal epithelial and immune cells in addition to acting as prebiotics.
To investigate whether a diet supplemented with plant-derived fructo-oligosaccharides (FOS) supports the efficacy of OIT in a murine cow's milk allergy model and to elucidate the potential mechanisms involved.
After oral sensitization to the cow's milk protein whey, female C3H/HeOuJ mice were fed either a control diet or a diet supplemented with FOS (1% w/w) and received OIT (10 mg whey) 5 days a week for 3 weeks by gavage. Intradermal (i.d.) and intragastric (i.g.) challenges were performed to measure acute allergic symptoms and mast cell degranulation. Blood and organs were collected to measure antibody levels and T cell and dendritic cell populations. Spleen-derived T cell fractions (whole spleen- and CD25-depleted) were transferred to naïve recipient mice to confirm the involvement of regulatory T cells (Tregs) in allergy protection induced by OIT + FOS.
OIT + FOS decreased acute allergic symptoms and mast cell degranulation upon challenge and prevented the challenge-induced increase in whey-specific IgE as observed in sensitized mice. Early induction of Tregs in the mesenteric lymph nodes (MLN) of OIT + FOS mice coincided with reduced T cell responsiveness in splenocyte cultures. CD25 depletion in OIT + FOS-derived splenocyte suspensions prior to transfer abolished protection against signs of anaphylaxis in recipients. OIT + FOS increased serum galectin-9 levels. No differences in short-chain fatty acid (SCFA) levels in the cecum were observed between the treatment groups. Concisely, FOS supplementation significantly improved OIT in the acute allergic skin response, %Foxp3+ Tregs and %LAP+ Th3 cells in MLN, and serum galectin-9 levels.
FOS supplementation improved the efficacy of OIT in cow's milk allergic mice. Increased levels of Tregs in the MLN and abolished protection against signs of anaphylaxis upon transfer of CD25-depleted cell fractions, suggest a role for Foxp3+ Tregs in the protective effect of OIT + FOS.
口服免疫疗法(OIT)是一种治疗食物过敏患者的有前景的治疗方法。然而,人们对其安全性和长期疗效存在一些担忧。使用不可消化的低聚糖可能会提高OIT的疗效,因为它们除了作为益生元外,还已知能直接调节肠道上皮细胞和免疫细胞。
研究补充植物来源的低聚果糖(FOS)的饮食是否能支持OIT在小鼠牛奶过敏模型中的疗效,并阐明其中涉及的潜在机制。
对牛奶蛋白乳清进行口服致敏后,给雌性C3H/HeOuJ小鼠喂食对照饮食或补充FOS(1% w/w)的饮食,并通过灌胃每周5天给予OIT(10mg乳清),持续3周。进行皮内(i.d.)和胃内(i.g.)激发试验以测量急性过敏症状和肥大细胞脱颗粒。收集血液和器官以测量抗体水平以及T细胞和树突状细胞群体。将脾脏来源的T细胞组分(全脾和去除CD25的)转移到未致敏的受体小鼠中,以确认调节性T细胞(Tregs)参与OIT + FOS诱导的过敏保护作用。
OIT + FOS减轻了激发后的急性过敏症状和肥大细胞脱颗粒,并防止了激发诱导的致敏小鼠中乳清特异性IgE的增加。OIT + FOS小鼠肠系膜淋巴结(MLN)中Tregs的早期诱导与脾细胞培养中T细胞反应性的降低相一致。转移前OIT + FOS来源的脾细胞悬液中的CD25去除消除了对受体过敏反应迹象的保护作用。OIT + FOS增加了血清半乳糖凝集素-9水平。各治疗组之间盲肠中短链脂肪酸(SCFA)水平没有差异。简而言之,补充FOS显著改善了OIT在急性过敏皮肤反应、MLN中%Foxp3 + Tregs和%LAP + Th3细胞以及血清半乳糖凝集素-9水平方面的效果。
补充FOS提高了OIT在牛奶过敏小鼠中的疗效。MLN中Tregs水平的增加以及去除CD25的细胞组分转移后对过敏反应迹象的保护作用消失,表明Foxp3 + Tregs在OIT + FOS的保护作用中发挥了作用。